Valuation Getinge AB OTC Markets
Stocks
GNGBY
US37427X1046
Medical Equipment, Supplies & Distribution
|
Market Closed -
OTC Markets
22:58:23 05/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 24.90 USD | +1.55% |
|
-1.55% | +5.29% |
| 09-29 | Millennium International Management no longer a public short seller in Getinge | FW |
| 09-28 | SB1 Markets sees underestimated margin potential at Getinge, raises price target | FW |
Company Valuation: Getinge AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 107,613 | 58,914 | 61,092 | 49,449 | 59,594 | 68,065 | - | - |
| Change | - | -45.25% | 3.7% | -19.06% | 20.52% | 14.21% | - | - |
| Enterprise Value (EV) 1 | 111,222 | 61,516 | 69,104 | 59,916 | 69,434 | 76,275 | 74,108 | 71,638 |
| Change | - | -44.69% | 12.34% | -13.3% | 15.89% | 9.85% | -2.84% | -3.33% |
| P/E | 36.2x | 23.6x | 25.3x | 30.2x | 26.4x | 21.5x | 19.2x | 17x |
| PBR | 4.27x | 1.93x | 2.01x | 1.49x | 2.02x | 2.13x | 2x | 1.85x |
| PEG | - | -1.5x | -7.98x | -0.9x | 0.7x | 0.5x | 1.6x | 1.3x |
| Capitalization / Revenue | 3.98x | 2.08x | 1.92x | 1.42x | 1.7x | 1.93x | 1.82x | 1.73x |
| EV / Revenue | 4.11x | 2.17x | 2.17x | 1.72x | 1.99x | 2.16x | 1.98x | 1.82x |
| EV / EBITDA | 16.5x | 10.4x | 12.4x | 9.02x | 10.6x | 10.6x | 9.59x | 8.55x |
| EV / EBIT | 22.5x | 15x | 18.9x | 13.2x | 15.5x | 15.1x | 13.3x | 11.7x |
| EV / FCF | 19.8x | 32.4x | 43.1x | 18.3x | 26.4x | 18.4x | 17.9x | 15.5x |
| FCF Yield | 5.06% | 3.08% | 2.32% | 5.45% | 3.79% | 5.45% | 5.59% | 6.44% |
| Dividend per Share 2 | 4 | 4.25 | 4.4 | 4.6 | 4.75 | 5.186 | 5.652 | 6.044 |
| Rate of return | 1.01% | 1.96% | 1.96% | 2.53% | 2.17% | 2.08% | 2.26% | 2.42% |
| EPS 2 | 10.9 | 9.15 | 8.86 | 6.01 | 8.29 | 11.6 | 13.03 | 14.71 |
| Distribution rate | 36.7% | 46.4% | 49.7% | 76.5% | 57.3% | 44.7% | 43.4% | 41.1% |
| Net sales 1 | 27,049 | 28,292 | 31,827 | 34,759 | 34,969 | 35,320 | 37,442 | 39,285 |
| EBITDA 1 | 6,754 | 5,891 | 5,574 | 6,646 | 6,581 | 7,178 | 7,731 | 8,374 |
| EBIT 1 | 4,939 | 4,096 | 3,653 | 4,549 | 4,494 | 5,049 | 5,564 | 6,106 |
| Net income 1 | 2,970 | 2,491 | 2,412 | 1,638 | 2,258 | 3,178 | 3,580 | 4,018 |
| Net Debt 1 | 3,609 | 2,602 | 8,012 | 10,467 | 9,840 | 8,210 | 6,043 | 3,573 |
| Reference price 2 | 395.10 | 216.30 | 224.30 | 181.55 | 218.80 | 249.90 | 249.90 | 249.90 |
| Nbr of stocks (in thousands) | 272,370 | 272,370 | 272,370 | 272,370 | 272,370 | 272,370 | - | - |
| Announcement Date | 1/28/22 A | 2/1/23 A | 2/1/24 A | 1/28/25 A | 1/27/26 A | - | - | - |
1SEK in Million2SEK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 29.3x | 3.93x | 15.19x | 2.57% | 173B | |
| 18.81x | 3.43x | 12.27x | 3.2% | 113B | |
| 22.18x | 4.35x | 15.2x | 1.26% | 109B | |
| 25.57x | 2.52x | 10.12x | 2.8% | 74.44B | |
| 17.25x | 0.2x | 12.62x | 0.75% | 60.1B | |
| 30x | 7.4x | 19.18x | 1.33% | 51.87B | |
| 34.82x | 3.38x | 11.57x | 2.17% | 49.21B | |
| 35.69x | 8.87x | 24.95x | -.--% | 41.52B | |
| 34.92x | 6.12x | 19.22x | -.--% | 32.79B | |
| Average | 27.61x | 4.47x | 15.59x | 1.57% | 78.34B | |
| Weighted average by Cap. | 26.17x | 4.06x | 14.77x | 1.95% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- GETI B Stock
- GNGBY Stock
- Valuation Getinge AB
Select your edition
All financial news and data tailored to specific country editions
